Logo image
Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse
Journal article   Open access   Peer reviewed

Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse

Liang Qiang, Emanuela Piermarini, Hemalatha Muralidharan, Wenqian Yu, Lanfranco Leo, Laura E Hennessy, Silvia Fernandes, Theresa Connors, Philip L Yates, Michelle Swift, …
Human molecular genetics, v 28(7), pp 1136-1152
01 Apr 2019
PMID: 30520996
url
https://doi.org/10.1093/hmg/ddy419View
Published, Version of Record (VoR)Open Access (License Unspecified) Open

Abstract

Animals Axonal Transport - physiology Axons - metabolism Disease Models, Animal Gain of Function Mutation - genetics Haploinsufficiency Haplotypes Mice Mice, Transgenic Microtubules - metabolism Mutant Proteins - genetics Mutation Neurons - metabolism Spastic Paraplegia, Hereditary - genetics Spastic Paraplegia, Hereditary - physiopathology Spastin - genetics Spastin - physiology
Mutations of the SPAST gene, which encodes the microtubule-severing protein spastin, are the most common cause of hereditary spastic paraplegia (HSP). Haploinsufficiency is the prevalent opinion as to the mechanism of the disease, but gain-of-function toxicity of the mutant proteins is another possibility. Here, we report a new transgenic mouse (termed SPASTC448Y mouse) that is not haploinsufficient but expresses human spastin bearing the HSP pathogenic C448Y mutation. Expression of the mutant spastin was documented from fetus to adult, but gait defects reminiscent of HSP (not observed in spastin knockout mice) were adult onset, as is typical of human patients. Results of histological and tracer studies on the mouse are consistent with progressive dying back of corticospinal axons, which is characteristic of the disease. The C448Y-mutated spastin alters microtubule stability in a manner that is opposite to the expectations of haploinsufficiency. Neurons cultured from the mouse display deficits in organelle transport typical of axonal degenerative diseases, and these deficits were worsened by depletion of endogenous mouse spastin. These results on the SPASTC448Y mouse are consistent with a gain-of-function mechanism underlying HSP, with spastin haploinsufficiency exacerbating the toxicity of the mutant spastin proteins. These findings reveal the need for a different therapeutic approach than indicated by haploinsufficiency alone.

Metrics

88 Record Views
28 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemistry & Molecular Biology
Genetics & Heredity
Logo image